Literature DB >> 11380033

Muscular dystrophy in female dogs.

G D Shelton1, L A Liu, L T Guo, G K Smith, J S Christiansen, W B Thomas, M O Smith, K L Kline, P A March, T Flegel, E Engvall.   

Abstract

The most common form of muscular dystrophy in dogs and humans is caused by mutations in the dystrophin gene. The dystrophin gene is located on the X chromosome, and, therefore, disease-causing mutations in dystrophin occur most often in males. Therefore, females with dystrophin deficiency or other forms of muscular dystrophy may be undiagnosed or misdiagnosed. Immunohistochemistry was used to analyze dystrophin and a number of other muscle proteins associated with muscular dystrophy in humans, including sarcoglycans and laminin alpha2, in muscle biopsy specimens from 5 female dogs with pathologic changes consistent with muscular dystrophy. The female dogs were presented with a variety of clinical signs including generalized weakness, muscle wasting, tremors, exercise intolerance, gait abnormalities, and limb deformity. Serum creatine kinase activity was variably high. One dog had no detectable dystrophin in the muscle; another was mosaic, with some fibers normal and others partly dystrophin-deficient. A 3rd dog had normal dystrophin but no detectable laminin alpha2. Two dogs could not be classified. This study demonstrates the occurrence of dystrophin- and laminin alpha2-associated muscular dystrophy and the difficulty in clinical diagnosis of these disorders in female dogs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380033     DOI: 10.1892/0891-6640(2001)015<0240:mdifd>2.3.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  11 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Laminin-211 in skeletal muscle function.

Authors:  Johan Holmberg; Madeleine Durbeej
Journal:  Cell Adh Migr       Date:  2012-11-15       Impact factor: 3.405

Review 3.  Dystrophin-deficient large animal models: translational research and exon skipping.

Authors:  Xinran Yu; Bo Bao; Yusuke Echigoya; Toshifumi Yokota
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

4.  Gait characteristics in a canine model of X-linked myotubular myopathy.

Authors:  Melissa A Goddard; Emily Burlingame; Alan H Beggs; Anna Buj-Bello; Martin K Childers; Anthony P Marsh; Valerie E Kelly
Journal:  J Neurol Sci       Date:  2014-08-29       Impact factor: 3.181

Review 5.  Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.

Authors:  Peter D Yurchenco; Karen K McKee; Judith R Reinhard; Markus A Rüegg
Journal:  Matrix Biol       Date:  2017-11-27       Impact factor: 11.583

6.  Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy.

Authors:  Peter P Nghiem; Luca Bello; Cindy Balog-Alvarez; Sara Mata López; Amanda Bettis; Heather Barnett; Briana Hernandez; Scott J Schatzberg; Richard J Piercy; Joe N Kornegay
Journal:  Mamm Genome       Date:  2016-12-27       Impact factor: 2.957

7.  Congenital muscular dystrophy in a dog with a LAMA2 gene deletion.

Authors:  G Diane Shelton; Katie M Minor; Stephanie Thomovsky; Ling T Guo; Steven G Friedenberg; Jonah N Cullen; James R Mickelson
Journal:  J Vet Intern Med       Date:  2021-12-02       Impact factor: 3.333

8.  Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.

Authors:  Karla P C Araujo; Gloria Bonuccelli; Caio N Duarte; Thais P Gaiad; Dayson F Moreira; David Feder; José E Belizario; Maria A Miglino; Michael P Lisanti; Carlos E Ambrosio
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  Clinical and genetic characterisation of dystrophin-deficient muscular dystrophy in a family of Miniature Poodle dogs.

Authors:  Lluís Sánchez; Elsa Beltrán; Alberta de Stefani; Ling T Guo; Anita Shea; G Diane Shelton; Luisa De Risio; Louise M Burmeister
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

10.  Long-term follow-up of laminin alpha2 (merosin)-deficient muscular dystrophy in a cat.

Authors:  Yuichi Awamura; Kazuyuki Uchida; Eri Arikawa-Hirasawa
Journal:  J Feline Med Surg       Date:  2008-02-20       Impact factor: 2.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.